MarketPeel
Insider Trading Intelligence
ML

Martin A. Lehr

CNTX
CHIEF EXECUTIVE OFFICER · CONTEXT THERAPEUTICS INC. · CIK 0001861989
FILING MIX · LIFETIME86%/14%
BUYS
25
SELLS
4
TOTAL VALUE
$1.03M
COMPANIES
1
ACTIVE SINCE
Oct 2021
HOLDINGS NOW
815,000
AVG SELL PX
TRADE KIND
SHOWING 29 / 29
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Martin A. Lehr, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+27.27%-2.05%-0.13%-1.93%-3.38%
14d11+36.36%+1.36%-0.03%+1.39%-5.16%
30d11+27.27%-9.34%-0.47%-8.87%-14.15%
60d11+18.18%-22.83%+0.32%-23.15%-25.97%
90d11+9.09%-25.87%+1.53%-27.40%-25.02%
180d11+72.73%+21.04%+7.24%+13.80%+28.03%
1y11+72.73%+19.73%+14.41%+5.32%+16.48%
2y11(1 pending)+50.00%+5.22%+42.09%-36.87%-43.16%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CNTX · 815,000 shares · as of Feb 19, 2026
0230,048460,095690,143920,19020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 25 buys / 4 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
815,000815,000Feb 19, 2026Feb 23, 2026View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
100,000$0.70$70.1K920,190Jun 9, 2025Jun 10, 2025View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
802,700802,700Feb 13, 2025Feb 14, 2025View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
291,402291,402Mar 21, 2024Mar 22, 2024View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
5,823$0.84$4.9K159,701Feb 21, 2023Feb 21, 2023View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
5,606$0.87$4.9K153,878Feb 13, 2023Feb 13, 2023View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
287,544287,544Feb 13, 2023Feb 14, 2023View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
5,040$0.97$4.9K148,272Feb 6, 2023Feb 6, 2023View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
7,027$0.70$4.9K143,232Jan 30, 2023Jan 30, 2023View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
6,839$0.72$4.9K136,205Jan 23, 2023Jan 23, 2023View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
6,783$0.74$5.0K129,366Jan 17, 2023Jan 18, 2023View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
20,000$0.74$14.8K122,583Dec 16, 2022Dec 19, 2022View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
13,000$1.85$24.1K102,583Aug 19, 2022Aug 22, 2022View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
254,300254,300Feb 25, 2022Feb 25, 2022View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
13,000$3.22$41.8K820,190Dec 16, 2021Dec 16, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
52,6800Oct 22, 2021Dec 17, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
10,000$5.00$50.0K807,190Oct 22, 2021Dec 17, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
52,680$7.14$376.1K0Oct 22, 2021Dec 17, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
10,000$5.00$50.0K99,583Oct 22, 2021Oct 25, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
SALE
Chief Executive Officer
586,4760Oct 22, 2021Oct 25, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
52,6800Oct 22, 2021Oct 25, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
52,680$7.14$376.1K52,680Oct 22, 2021Oct 25, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
SALE
Chief Executive Officer
210,7220Oct 22, 2021Oct 25, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
210,722263,402Oct 22, 2021Oct 25, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
586,476849,878Oct 22, 2021Oct 25, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
SALE
Chief Executive Officer
210,7157Oct 22, 2021Dec 17, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
586,475797,190Oct 22, 2021Dec 17, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
SALE
Chief Executive Officer
586,4751Oct 22, 2021Dec 17, 2021View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
210,715210,715Oct 22, 2021Dec 17, 2021View →
Other insiders · CNTX
Loading peer insiders…
About this filer
CIK 0001861989
ROLE
Chief Executive Officer
PRIMARY
CNTX
COMPANIES
1
ACTIVE SINCE
Oct 2021
MARKETPEEL · /INSIDER/0001861989DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback